A new trading day began on Monday, with 2seventy bio Inc (NASDAQ: TSVT) stock price up 7.87% from the previous day of trading, before settling in for the closing price of $4.26. TSVT’s price has ranged from $1.53 to $12.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 73.45%. Meanwhile, its annual earnings per share averaged 56.23%. With a float of $47.64 million, this company’s outstanding shares have now reached $50.63 million.
Let’s determine the extent of company efficiency that accounts for 274 employees.
2seventy bio Inc (TSVT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of 2seventy bio Inc is 7.16%, while institutional ownership is 93.32%. The most recent insider transaction that took place on Mar 26 ’24, was worth 203,992. In this transaction Director of this company bought 40,000 shares at a rate of $5.10, taking the stock ownership to the 2,000,000 shares. Before that another transaction happened on Mar 25 ’24, when Company’s Director bought 330,000 for $5.07, making the entire transaction worth $1,673,991. This insider now owns 1,960,000 shares in total.
2seventy bio Inc (TSVT) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2023, the company reported earnings of -1.08 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.23% per share during the next fiscal year.
2seventy bio Inc (NASDAQ: TSVT) Trading Performance Indicators
Here are 2seventy bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.41, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of 2seventy bio Inc (TSVT)
Looking closely at 2seventy bio Inc (NASDAQ: TSVT), its last 5-days average volume was 1.09 million, which is a drop from its year-to-date volume of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 53.31%. Additionally, its Average True Range was 0.48.
During the past 100 days, 2seventy bio Inc’s (TSVT) raw stochastic average was set at 58.64%, which indicates a significant increase from 55.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.56% in the past 14 days, which was lower than the 104.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.03, while its 200-day Moving Average is $4.56. However, in the short run, 2seventy bio Inc’s stock first resistance to watch stands at $4.77. Second resistance stands at $4.95. The third major resistance level sits at $5.24. If the price goes on to break the first support level at $4.30, it is likely to go to the next support level at $4.01. Should the price break the second support level, the third support level stands at $3.83.
2seventy bio Inc (NASDAQ: TSVT) Key Stats
With a market capitalization of 235.51 million, the company has a total of 51,311K Shares Outstanding. Currently, annual sales are 100,390 K while annual income is -217,570 K. The company’s previous quarter sales were 10,680 K while its latest quarter income was -56,820 K.
